about
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous systemFluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castleA new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaFocus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human gliomaCNS immune privilege: hiding in plain sight.Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sitesAre Microglial Cells the Regulators of Lymphocyte Responses in the CNS?Immunotherapy advances for glioblastomaNeural stem cell niches in health and diseasesRedox control of microglial function: molecular mechanisms and functional significanceImmunotherapy for brain cancer: recent progress and future promiseAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaVascular, glial, and lymphatic immune gateways of the central nervous systemImmune privilege: keeping an eye on natural killer T cells.The blood-testis and blood-epididymis barriers are more than just their tight junctions.Regulatory T cells in CNS injury: the simple, the complex and the confusedGlial grafting for demyelinating disease.Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cells.Dynamics of central and peripheral immunomodulation in a murine glioma model.Knocking at the brain's door: intravital two-photon imaging of autoreactive T cell interactions with CNS structuresTransplantation into the human brain: present status and future possibilities.The Sertoli cell: one hundred fifty years of beauty and plasticity.Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro.A local autocrine axis in the testes that regulates spermatogenesis.Adenovirus-mediated gene delivery and in vitro microinsemination produce offspring from infertile male mice.Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus.Upregulation and induction of surface antigens with special reference to MHC class II expression in microglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharideRecent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy.Testicular defense systems: immune privilege and innate immunity.Inducible immune regulation following autoimmune disease in the immune-privileged eyeTraumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration.Infection-mediated vasoactive peptides modulate cochlear uptake of fluorescent gentamicin.Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system.Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.All in the head: obstacles for immune rejection of brain tumours.NLRs in immune privileged sitesBrain-reactive antibodies and disease.Molecular pathogenesis of neuroinflammation.A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cellsInduction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects.
P2860
Q21129488-09C94C3B-C764-4E72-A198-955CC868BF4CQ21195861-8C4D8781-5988-4E0D-903B-6762548D3813Q24307739-19A62B99-4022-42A8-A3DC-B95E5144BD9BQ24615166-14223A03-FF8E-4D8C-B869-BE9DA6F55F2AQ24642697-C35B920C-BEF1-4E0E-905B-980023AEC358Q24794781-BB811662-54F5-45D5-9941-A19284FD195BQ26774826-49F54C1D-50EB-4B4A-9D82-39E453CC7391Q26866513-238D0BE2-5A03-4320-824F-BF716F460E8AQ26995185-EB942DFD-580C-4AC8-AAB5-BCE42C30882BQ27000279-EACB2714-8427-47C7-A9E4-7E20637D9014Q27015881-08DDAAB0-093B-49BB-916A-FDAB08C357B7Q27024830-2CE05495-1957-40C0-B670-42490FC956CEQ28071461-A5EB778B-7AB6-419E-BAAA-D7AB14318F3FQ30050558-5ED959C2-2F39-4619-9598-98E60134A55AQ30370802-1C4D1746-3AC3-4038-BDCD-94C1DBC057F7Q30424827-41F4DE1D-3CEF-46A0-86C4-1F2080E96FEEQ30500898-6FA4740C-2012-4A25-9B95-ED13B9812A60Q33214095-2BA3EB4D-C6CA-4776-BFB7-D9F1E83C2C0CQ33410400-002AF8A3-41C1-4DAF-8A25-F3D520C2FA47Q33630513-C959D20A-DA3B-44B0-82B1-3B686C1BD96BQ33631689-AA37A797-B745-4F82-B584-839080FAEEEDQ33772289-C4B4F357-16D6-4B7E-BE6C-B38567F396B0Q33775611-33AA49BB-D255-487A-806E-D5B71CFE3EEFQ33841603-7C44EBF1-E462-4476-8BB9-E9C15F2D3286Q34009445-F3EBE9C6-D0A7-4568-9F10-A365869D2BCEQ34043161-241D3E00-528B-46D6-9FD8-9E138693EC21Q34087437-F31207C5-65DE-4CCD-84CD-CC054E824103Q34098055-F76D8A8A-B9D2-4A12-A5D0-02034B6D1711Q34339788-9A08827D-CC10-42B4-B736-08617B343218Q34342577-71787763-3EE8-4DB2-BD99-663FE9CF49BBQ34374669-96EC0683-ED97-4C8B-86B3-69FA4BAA0D70Q34500833-087092FA-B374-48EB-A712-00F133A1067FQ34610816-ED361BA0-942A-4610-AAD2-D7975ACAFECAQ34718313-6B7BFA2E-8722-4705-8B33-DCBD4BEF6FF6Q34842204-5F79871E-EF2E-4FB8-B9D2-7D7BD5CCDAB4Q35169896-AF877921-9427-419B-BD8B-9D9C90D18174Q35458567-7B54A40C-598B-42FA-835A-BC6489744584Q35564938-AE204307-7398-43D0-BC48-48BEC0C2F1FEQ35743874-E5E0546A-8AC7-45BD-9BB7-51FD336E1447Q35836251-32DD84B9-B377-4442-BC73-4B27C9DB84A0
P2860
description
1977 nî lūn-bûn
@nan
1977 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Immunologically privileged sites.
@ast
Immunologically privileged sites.
@en
Immunologically privileged sites.
@nl
type
label
Immunologically privileged sites.
@ast
Immunologically privileged sites.
@en
Immunologically privileged sites.
@nl
prefLabel
Immunologically privileged sites.
@ast
Immunologically privileged sites.
@en
Immunologically privileged sites.
@nl
P1476
Immunologically privileged sites.
@en
P2093
Billingham RE
P577
1977-01-01T00:00:00Z